The Investor Relations website contains information about Blueprint Medicines Corp.'s business for stockholders, potential investors, and financial ...
Investor contacts Jenna Cohen Vice President and Head, Investor Relations 857-209-3147 Cassie Saitow Associate Director, Investor Relations 617.909.3127 · ir ...
People also ask
What kind of company is Blueprint Medicines?
Is Blueprint a publicly traded company?
How many employees does Blueprint Medicines have?
What is the address for Blueprint Medicines?
Whom should I contact if I have future questions? You can submit questions to Blueprint's investor relations department by contacting ir@blueprintmedicines.com ...
NASDAQ: BPMC (common stock). $89.47. -2.83 (-3.07 ... Investor contact Jenna Cohen Senior Director, Head of Investor Relations ir ... Annual Report. Privacy notice ...
CAMBRIDGE, Mass., Feb. 15, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business ...
According to Zacks Investment Research, based on 10 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.64. The reported EPS for the same ...
Senior Director & Head of Investor Relations, --, --, --. Blueprint Medicines Corporation. 45 Sidney Street. Cambridge, MA 02139. United States. 617 374 7580 ...
1 day ago · Wall Street expects a year-over-year increase in earnings on higher revenues when Blueprint Medicines (BPMC) reports results for the quarter ...
Apr 11, 2024 · The Investor Relations website contains information about Blueprint Medicines Corp.'s business for stockholders, potential investors, and ...